Eisai
4523.T
#2184
Rank
ยฃ6.35 B
Marketcap
ยฃ22.52
Share price
0.11%
Change (1 day)
-1.86%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: ยฃ0.39 Billion

According to Eisai's latest financial reports the company's current earnings are ยฃ5.06 Billion. In 2023 the company made an earning of ยฃ0.39 Billion, an increase over its 2022 earnings that were of -ยฃ17.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023ยฃ0.39 B-2404.04%
2022-ยฃ17.1 Million-103.6%
2021ยฃ0.47 B-39.81%
2020ยฃ0.78 B7.44%
2019ยฃ0.73 B17.22%
2018ยฃ0.62 B86.16%
2017ยฃ0.33 B-23.52%
2016ยฃ0.44 B26.97%
2015ยฃ0.34 B22.3%
2014ยฃ0.28 B-46.07%
2013ยฃ0.52 B-21.85%
2012ยฃ0.67 B-20.59%
2011ยฃ0.84 B-8.91%
2010ยฃ0.93 B19.21%
2009ยฃ0.78 B